aid: ancora-biotech
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/ancora-biotech.png
name: Ancora Biotech
description: Ancora Biotech is a clinical-stage biopharmaceutical company developing breakthrough
  biotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infection. Formed
  by former Teneobio executives and venture investors, it oversees three therapeutic programs across
  separate spinoffs — TeneoTwo (TNB-486, a T cell engager in Phase I for B-cell malignancies),
  TeneoFour (TNB-738, an anti-CD38 antibody for inflammatory and metabolic disorders), and TeneoTen
  (an anti-HBV T cell engager for hepatitis B). It is a drug-development company with no public
  developer API or platform surface.
url: https://raw.githubusercontent.com/api-evangelist/ancora-biotech/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
- sutter-hill-ventures
x-tier: stub
x-tier-reason: portfolio-lead
x-no-api-surface: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Biopharmaceutical
- Healthcare
- Life Sciences
- Immunotherapy
- Oncology
common:
- type: Website
  url: https://www.ancorabiotech.com
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence